HOME >> MEDICINE >> NEWS
Antibiotic rifampicin shows promise for fighting Parkinson's disease in lab tests

SANTA CRUZ, CA--Researchers at the University of California, Santa Cruz, have shown that rifampicin, an antibiotic used to treat leprosy and tuberculosis, can prevent the formation of protein fibrils associated with the death of brain cells in people with Parkinson's disease. The drug also dissolved existing fibrils in laboratory tests.

The researchers studied the effects of rifampicin in test tube experiments and are currently doing studies with cell cultures and mice to see if the same effects occur in living cells. Although these are just the first steps along the path toward clinical studies in humans, the findings suggest that rifampicin and related compounds might be effective in preventing fibril formation and associated neurological damage in patients with Parkinson's disease, said Anthony Fink, professor of chemistry and biochemistry at UCSC.

"Clearly, more work is needed to determine if this would work therapeutically, but if it does it would probably be most useful as a prophylactic therapy used in the early stages of the disease before there is general neurological damage," Fink said.

The research was carried out by a team of scientists in Fink's lab, including postdoctoral researchers Jie Li, Min Zhu, and Sudha Rajamani and research associate Vladimir Uversky. Li is first author of a paper describing their results in the November issue of the journal Chemistry and Biology, which is mailed and published online on November 29.

Aggregation of the protein known as alpha-synuclein into insoluble fibrils is thought to be a critical step in the development of Parkinson's disease, a progressive movement disorder resulting from the death of nerve cells in the brain that produce the neurotransmitter dopamine. Deposits called Lewy bodies, composed mostly of alpha-synuclein fibrils, appear in affected nerve cells, but the connection between the fibrils and cell death remains controversial, Fink said.

"There are t
'"/>

Contact: Tim Stephens
stephens@ucsc.edu
831-459-4352
University of California - Santa Cruz
29-Nov-2004


Page: 1 2 3

Related medicine news :

1. Antibiotics protect nerves in mice by turning on genes
2. Antibiotics within 4 hours of arrival at hospital better for pneumonia patients
3. Antibiotic provides promise in treatment of spinal cord injuries
4. Antibiotic resistant bacteria frequently transmitted between intensive care patients
5. Antibiotic use on swine farms increases efficiency, profits
6. Antibiotic slows atherosclerosis in people with Chlamydia pneumonia antibodies
7. Antibiotics not always beneficial for childhood ear infections
8. Antibiotic could offer promise for treatment of cystic fibrosis
9. Antibiotics help heart patients
10. Antibiotic prescription patterns violate guidelines, increase costs
11. Antibiotic prescribing in local communities is linked to localised resistance

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... announced the 10th Anniversary of Blood Cancer Awareness Month (BCAM) and its international ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... of innovative higher-learning opportunities through high-quality, career-relevant, and affordable online education – is ... Psychology . , Among the first of its kind in the nation, ...
(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang has over 20 ... and other developmental disabilities, as well as supporting staff in caring for patients ... school consultation, and staff development. She joined the company in 2015 as Chief ...
(Date:8/28/2020)... , ... August 28, 2020 , ... ... one-year subscription to a customized Lighthouse Health & Wellness mobile app and web-portal. ... this project. Motorola Solutions Foundation awards grants each year to organizations, such as ...
(Date:8/27/2020)... ... August 27, 2020 , ... ... Walk-in Dermatology team in its Greenvale, New York location. , Loren received ... Care Institute. She is certified in chemical peels, microdermabrasion, Hydrafacial MD, dermaplaning, facial ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... ... August 27, 2020 , ... InfoMC, a ... successful completion of their 2020 System and Organizational Controls (SOC) 1® Type 2 ... and MARS-E compliance assessment. These achievements reflect their long-standing commitment to privacy, security, ...
(Date:8/27/2020)... ... August 27, 2020 , ... Trella Health, the leading source ... of cloud CRM, marketing automation, and contact center solutions for senior living communities ... of Trella’s performance intelligence data and insights into Enquire’s CRM solution to serve ...
(Date:8/26/2020)... ... August 26, 2020 , ... AseptiScope, a privately funded San Diego, California ... Year by MedTech Outlook. , “AseptiScope is pleased to receive this recognition,” ... who wear gloves on their hands, goggles on their eyes, covers on their shoes, ...
Breaking Medicine Technology:
Cached News: